$EYPT A Market Cap of just $163M seems incredibly low for a company with 2 new FDA approved products both of which have HUGE potential. This is a situation in which contrarians can make a fortune. When this $10 there will be plenty of people saying: Wish I had bought it under $2.
  • 5
  • 1